Afamelanotide is approved in both the European Union and the United States for the treatment of erythropoietic protoporphyria (EPP), a rare and debilitating photodermatosis characterized by severe pain upon sun exposure
Plateaus are a normal physiological response during extended weight loss treatment and do not necessarily indicate treatment failure or medication resistance
Research shows that most people regain significant weight when stopping GLP-1 medications if they do not maintain intensive lifestyle modifications
Alt Text: Retatrutide peptide mechanism diagram showing GIP, GLP-1, and glucagon receptor pathways Full AI Image Prompt: Create a clean clinical infographic titled Retatrutide Triple-Receptor Mechanism. Show an abstract retatrutide peptide icon in the center with three clearly labeled branches to GIP receptor, GLP-1 receptor, and Glucagon receptor. Under each receptor, include short neutral labels: insulin response research, appetite and glucose signaling, and energy metabolism research. Use a modern medical editorial style, white background, subtle blue and green accents, simple vector icons, no people, no syringes, no product packaging, no before-and-after imagery, and no guaranteed outcome language
Injection: How to Choose For residents in Stockbridge, Georgia, the debate between "tirzepatide oral vs injection" is significant for those seeking alternatives to injections